NOS3 and endothelial dysfunction: Mechanisms involved in the beneficial intrahepatic effects of statins include improvement of endothelial dysfunction through increasing endothelial nitric oxide synthase (eNOS) activity (by an increment in eNOS phosphorylation at serine 1176 [1177 in the human sequence])10 and inhibition of RhoA/Rho-kinase11.